Exposure to asbestos is associated with various pathologies, such as asbestosis, mesothelioma, and pleural plaques. As treatment for these disorders is not curative, the main aim should be to limit exposure.
Recent advances in the molecular knowledge of small-cell lung cancer are outlined, as are promising new treatment strategies, including those targeting the DNA damage pathway, oncogenic drivers, and epigenetics.
An exploration of the potential impact of hormone replacement therapy in women on the most commonly occurring lung diseases, such as asthma, lung cancer, and pulmonary hypertension.
A discussion of lung microbiome dysbiosis in various chronic respiratory disorders and the mechanisms by which these bacteria can cause or contribute to the severity of disease.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
Among the most common molecular alterations detected in non-small-cell lung cancer (NSCLC) are mutations in Kristen Rat Sarcoma viral oncogene homolog (KRAS). KRAS mutant NSCLC is a heterogenous group of diseases, different from other …
Lung cancer, a multifaceted disease, demands tailored therapeutic approaches due to its diverse subtypes and stages. This comprehensive review explores the intricate landscape of lung cancer research, delving into recent breakthroughs and their …
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality. Approximately 1.8 million deaths worldwide will be attributable to this disease in 2020. Recent years have seen significant improvements in survival of patients …
Lung cancer is a type of cancer that can metastasize to the lungs, brain, bones, liver, adrenal glands, and other organs; however, the occurrence of brain metastases is the most common event. Symptoms of brain metastasis include motor dysfunction …
Expert-led, multiformat program which will address the individualized management of NSCLC, through education on the detection of NTRK gene fusions, current evidence-based guidelines, and new and emerging therapies. Will also include guidance on integrating shared decision making into your clinical practice, drawing on insights from a patient on how best to communicate.
In lung cancer, the ability of Positron Emission Tomography (PET) with [18F]fluoro-2-deoxy-D-glucose (FDG) to exploit the biochemical differences between normal and neoplastic tissue [ 1 ] has been proven to be a valuable tool for tumor detection [ …2
Lung cancer represents one of the leading causes of cancer-related deaths, but substantial advances have been made in enhancing the ways in which lung cancers are histologically identified and molecularly profiled. As a result, several targeted …
The role of segmentectomy has expanded to include resection of peripheral small-sized early non-small-cell lung cancer (NSCLC), as this technique may better preserve the lung function than lobectomy [ 1 , 2 ]. Recently, a Japanese randomized …
Compared with traditional open thoracotomy, thoracoscopic minimally invasive surgery has many advantages. It requires a small incision, causes minimal trauma and less pain, and allows faster recovery [ 1 ]. Therefore, thoracoscopic minimally …
